Mode
Text Size
Log in / Sign up

What is the overall chance of having psychosis if I have lupus?

high confidence  ·  Last reviewed May 16, 2026

If you have lupus (systemic lupus erythematosus, SLE), the chance of developing psychosis is relatively low but real. A comprehensive meta-analysis of over 31,000 adults with SLE found that about 4.5% experience psychosis at some point 2. This means that for every 100 people with lupus, roughly 4 or 5 will have a psychotic episode. The risk is higher if lupus affects the nervous system (neuropsychiatric SLE, or NPSLE) — in that group, about 20.5% develop psychosis 2. Psychosis in lupus often appears within the first two years of the disease and is linked to higher disease activity and certain antibodies 2.

What the research says

The best available estimate comes from a 2024 meta-analysis that pooled 65 studies with 31,495 adult SLE patients 2. The overall prevalence of psychosis was 4.5% (95% confidence interval: 3.6% to 5.5%) 2. Among patients whose lupus had already caused neuropsychiatric symptoms (NPSLE), the rate jumped to 20.5% 2. This means that while psychosis is uncommon in the general lupus population, it is a significant concern when the brain is already involved.

Psychosis in lupus is not random. The same meta-analysis found that it is strongly associated with higher overall lupus disease activity, the presence of anti-ribosomal P antibodies, antiphospholipid antibodies, and low complement levels (a sign of immune activation) 2. Most cases occurred within two years of the lupus diagnosis 2. Delusions and hallucinations are the typical symptoms 2.

Other research supports that psychosis runs in some lupus families. A study of sibling pairs with lupus found that neurologic disorder (defined as seizure or psychosis) had a sibling risk ratio of 1.9 to 3.9, meaning that if one sibling with lupus has psychosis, the other sibling with lupus is about 2 to 4 times more likely to also have it compared to the general lupus population 8. This suggests a genetic component.

For treatment, a meta-analysis of rituximab (a biologic therapy) in refractory lupus with neurological or psychiatric symptoms showed a 90% clinical response rate (partial or major improvement) 7. However, about one-third of responders later relapsed, with a median time to relapse of 9.5 months 7. This indicates that while treatment can be effective, ongoing monitoring is needed.

What to ask your doctor

  • Given my lupus activity and antibody profile, what is my personal risk for developing psychosis?
  • What symptoms should I watch for that could signal psychosis (like hallucinations, delusions, or confusion)?
  • If I have neuropsychiatric symptoms, what treatments are available and what are their risks and benefits?
  • How often should I be monitored for signs of brain involvement in my lupus?
  • Are there any lifestyle changes or medications that can lower my risk of lupus-related psychosis?

This question is drawn from common patient questions about Rheumatology and answered using cited medical research. We do not provide individualized advice.